These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction. Kim MS; Kim SW; Han TY; Son SJ; Lee JH; Kim EJ Int J Dermatol; 2014 Apr; 53(4):e267-8. PubMed ID: 24117439 [No Abstract] [Full Text] [Related]
3. US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone. Chan VC; La Grenade L; Diak IL; Levin RL J Clin Psychiatry; 2015 Sep; 76(9):e1138-9. PubMed ID: 26455682 [No Abstract] [Full Text] [Related]
4. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient. Tsai CF; Tsai SJ; Hwang JP Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110 [No Abstract] [Full Text] [Related]
5. The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases. Eker SS; Sarandol A; Akkaya C; Sivrioglu EY; Kirli S J Psychopharmacol; 2009 Nov; 23(8):993-6. PubMed ID: 18635710 [TBL] [Abstract][Full Text] [Related]
6. Serotonin syndrome caused by ziprasidone alone. Lin PY; Hong CJ; Tsai SJ Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736 [No Abstract] [Full Text] [Related]
7. Tardive dyskinesia and ziprasidone. Rosenquist KJ; Walker SS; Ghaemi SN Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846 [No Abstract] [Full Text] [Related]
8. Tardive dystonia associated with ziprasidone. Papapetropoulos S; Wheeler S; Singer C Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868 [No Abstract] [Full Text] [Related]
9. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge. Gray NS Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855 [TBL] [Abstract][Full Text] [Related]
10. Sudden akathisia after a ziprasidone dose reduction. Oral ET; Altinbas K; Demirkiran S Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883 [No Abstract] [Full Text] [Related]
11. Ziprasidone-induced acute dystonia. Mason MN; Johnson CE; Piasecki M Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487 [No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. Ozen ME; Yumru M; Savas HA; Cansel N; Herken H World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349 [TBL] [Abstract][Full Text] [Related]